Cloning and expression in Pichia pastoris of metalloprotease domain of ADAM 9 catalytically active against fibronectin

Schwettmann L, Tschesche H (2001)
PROTEIN EXPRESSION AND PURIFICATION 21(1): 65-70.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Schwettmann, L; Tschesche, HaraldUniBi
Abstract / Bemerkung
ADAM 9 is a member of the cellular metalloprotease/ disintegrin/cysteine-rich (MDC) gene family, related to soluble snake venom metalloproteases (SVMP). ADAMs may play important roles in cell-cell fusion, cell-matrix interaction, and other cellular functions. To investigate catalytic activity of human ADAM 9 we have cloned and expressed the metalloprotease domain of human ADAM 9 in Pichia pastoris. The recombinant protein was purified in a three-step purification procedure and activity was detected against gelatin, p-casein, and fibronectin. In addition we identified five normal and cancer cell lines expressing mRNA of human ADAM 9. (C) 2001 Academic Press.
Erscheinungsjahr
2001
Zeitschriftentitel
PROTEIN EXPRESSION AND PURIFICATION
Band
21
Ausgabe
1
Seite(n)
65-70
ISSN
1046-5928
Page URI
https://pub.uni-bielefeld.de/record/1617925

Zitieren

Schwettmann L, Tschesche H. Cloning and expression in Pichia pastoris of metalloprotease domain of ADAM 9 catalytically active against fibronectin. PROTEIN EXPRESSION AND PURIFICATION. 2001;21(1):65-70.
Schwettmann, L., & Tschesche, H. (2001). Cloning and expression in Pichia pastoris of metalloprotease domain of ADAM 9 catalytically active against fibronectin. PROTEIN EXPRESSION AND PURIFICATION, 21(1), 65-70. https://doi.org/10.1006/prep.2000.1374
Schwettmann, L, and Tschesche, Harald. 2001. “Cloning and expression in Pichia pastoris of metalloprotease domain of ADAM 9 catalytically active against fibronectin”. PROTEIN EXPRESSION AND PURIFICATION 21 (1): 65-70.
Schwettmann, L., and Tschesche, H. (2001). Cloning and expression in Pichia pastoris of metalloprotease domain of ADAM 9 catalytically active against fibronectin. PROTEIN EXPRESSION AND PURIFICATION 21, 65-70.
Schwettmann, L., & Tschesche, H., 2001. Cloning and expression in Pichia pastoris of metalloprotease domain of ADAM 9 catalytically active against fibronectin. PROTEIN EXPRESSION AND PURIFICATION, 21(1), p 65-70.
L. Schwettmann and H. Tschesche, “Cloning and expression in Pichia pastoris of metalloprotease domain of ADAM 9 catalytically active against fibronectin”, PROTEIN EXPRESSION AND PURIFICATION, vol. 21, 2001, pp. 65-70.
Schwettmann, L., Tschesche, H.: Cloning and expression in Pichia pastoris of metalloprotease domain of ADAM 9 catalytically active against fibronectin. PROTEIN EXPRESSION AND PURIFICATION. 21, 65-70 (2001).
Schwettmann, L, and Tschesche, Harald. “Cloning and expression in Pichia pastoris of metalloprotease domain of ADAM 9 catalytically active against fibronectin”. PROTEIN EXPRESSION AND PURIFICATION 21.1 (2001): 65-70.

21 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Fine Tuning Cell Migration by a Disintegrin and Metalloproteinases.
Dreymueller D, Theodorou K, Donners M, Ludwig A., Mediators Inflamm 2017(), 2017
PMID: 28260841
ADAM and ADAMTS family proteins and their role in the colorectal cancer etiopathogenesis.
Przemyslaw L, Boguslaw HA, Elzbieta S, Malgorzata SM., BMB Rep 46(3), 2013
PMID: 23527857
Accelerated wound repair in ADAM-9 knockout animals.
Mauch C, Zamek J, Abety AN, Grimberg G, Fox JW, Zigrino P., J Invest Dermatol 130(8), 2010
PMID: 20376065
Variability in melanoma metalloproteinase expression profiling.
Giricz O, Lauer JL, Fields GB., J Biomol Tech 21(4), 2010
PMID: 21119930
Loss of the metalloprotease ADAM9 leads to cone-rod dystrophy in humans and retinal degeneration in mice.
Parry DA, Toomes C, Bida L, Danciger M, Towns KV, McKibbin M, Jacobson SG, Logan CV, Ali M, Bond J, Chance R, Swendeman S, Daniele LL, Springell K, Adams M, Johnson CA, Booth AP, Jafri H, Rashid Y, Banin E, Strom TM, Farber DB, Sharon D, Blobel CP, Pugh EN, Pierce EA, Inglehearn CF., Am J Hum Genet 84(5), 2009
PMID: 19409519
Characterization of a novel ADAM protease expressed by Pneumocystis carinii.
Kennedy CC, Kottom TJ, Limper AH., Infect Immun 77(8), 2009
PMID: 19451239
ADAM9 expression is a significant and independent prognostic marker of PSA relapse in prostate cancer.
Fritzsche FR, Jung M, Tölle A, Wild P, Hartmann A, Wassermann K, Rabien A, Lein M, Dietel M, Pilarsky C, Calvano D, Grützmann R, Jung K, Kristiansen G., Eur Urol 54(5), 2008
PMID: 18061337
Hepatic expression of A disintegrin and metalloproteinase (ADAM) and ADAMs with thrombospondin motives (ADAM-TS) enzymes in patients with chronic liver diseases.
Schwettmann L, Wehmeier M, Jokovic D, Aleksandrova K, Brand K, Manns MP, Lichtinghagen R, Bahr MJ., J Hepatol 49(2), 2008
PMID: 18490073
ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression.
Fritzsche FR, Wassermann K, Jung M, Tölle A, Kristiansen I, Lein M, Johannsen M, Dietel M, Jung K, Kristiansen G., BMC Cancer 8(), 2008
PMID: 18582378
Implication of ADAM-8, -9, -10, -12, -15, -17, and ADAMTS-1 in implantational remodeling of a mouse uterus.
Kim J, Kang SG, Kim JI, Park JH, Kim SK, Cho DJ, Kim H., Yonsei Med J 47(4), 2006
PMID: 16941747
Adam-9 expression and regulation in human skin melanoma and melanoma cell lines.
Zigrino P, Mauch C, Fox JW, Nischt R., Int J Cancer 116(6), 2005
PMID: 15856464
Human ADAM33 messenger RNA expression profile and post-transcriptional regulation.
Umland SP, Garlisi CG, Shah H, Wan Y, Zou J, Devito KE, Huang WM, Gustafson EL, Ralston R., Am J Respir Cell Mol Biol 29(5), 2003
PMID: 12777249
Expression of ADAM-9 mRNA and protein in human breast cancer.
O'Shea C, McKie N, Buggy Y, Duggan C, Hill AD, McDermott E, O'Higgins N, Duffy MJ., Int J Cancer 105(6), 2003
PMID: 12767059
ADAMs: modulators of cell-cell and cell-matrix interactions.
White JM., Curr Opin Cell Biol 15(5), 2003
PMID: 14519395
Inverse regulation of the ADAM-family members, decysin and MADDAM/ADAM19 during monocyte differentiation.
Fritsche J, Müller A, Hausmann M, Rogler G, Andreesen R, Kreutz M., Immunology 110(4), 2003
PMID: 14632642
A secreted form of human ADAM9 has an alpha-secretase activity for APP.
Hotoda N, Koike H, Sasagawa N, Ishiura S., Biochem Biophys Res Commun 293(2), 2002
PMID: 12054541
The cysteine-rich domain regulates ADAM protease function in vivo.
Smith KM, Gaultier A, Cousin H, Alfandari D, White JM, DeSimone DW., J Cell Biol 159(5), 2002
PMID: 12460986

18 References

Daten bereitgestellt von Europe PubMed Central.

The cell surface metalloprotease/disintegrin Kuzbanian is required for axonal extension in Drosophila.
Fambrough D, Pan D, Rubin GM, Goodman CS., Proc. Natl. Acad. Sci. U.S.A. 93(23), 1996
PMID: 8917574
ADAMs in fertilization and development.
Wolfsberg TG, White JM., Dev. Biol. 180(2), 1996
PMID: 8954712
ADAMs: focus on the protease domain.
Black RA, White JM., Curr. Opin. Cell Biol. 10(5), 1998
PMID: 9818177
Regulation of human ADAM 12 protease by the prodomain. Evidence for a functional cysteine switch.
Loechel F, Overgaard MT, Oxvig C, Albrechtsen R, Wewer UM., J. Biol. Chem. 274(19), 1999
PMID: 10224107
A metalloprotease-disintegrin participating in myoblast fusion.
Yagami-Hiromasa T, Sato T, Kurisaki T, Kamijo K, Nabeshima Y, Fujisawa-Sehara A., Nature 377(6550), 1995
PMID: 7566181
A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells.
Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, Castner BJ, Stocking KL, Reddy P, Srinivasan S, Nelson N, Boiani N, Schooley KA, Gerhart M, Davis R, Fitzner JN, Johnson RS, Paxton RJ, March CJ, Cerretti DP., Nature 385(6618), 1997
PMID: 9034190
Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha.
Moss ML, Jin SL, Milla ME, Bickett DM, Burkhart W, Carter HL, Chen WJ, Clay WC, Didsbury JR, Hassler D, Hoffman CR, Kost TA, Lambert MH, Leesnitzer MA, McCauley P, McGeehan G, Mitchell J, Moyer M, Pahel G, Rocque W, Overton LK, Schoenen F, Seaton T, Su JL, Becherer JD., Nature 385(6618), 1997
PMID: 9034191
Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival.
Lum L, Wong BR, Josien R, Becherer JD, Erdjument-Bromage H, Schlondorff J, Tempst P, Choi Y, Blobel CP., J. Biol. Chem. 274(19), 1999
PMID: 10224132
Metalloprotease-disintegrin MDC9: intracellular maturation and catalytic activity.
Roghani M, Becherer JD, Moss ML, Atherton RE, Erdjument-Bromage H, Arribas J, Blackburn RK, Weskamp G, Tempst P, Blobel CP., J. Biol. Chem. 274(6), 1999
PMID: 9920899
A metalloprotease-disintegrin, MDC9/meltrin-gamma/ADAM9 and PKCdelta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor.
Izumi Y, Hirata M, Hasuwa H, Iwamoto R, Umata T, Miyado K, Tamai Y, Kurisaki T, Sehara-Fujisawa A, Ohno S, Mekada E., EMBO J. 17(24), 1998
PMID: 9857183
Cleavage of structural proteins during the assembly of the head of bacteriophage T4
Laemmli, Nature 15(), 1970
Quantitative zymography: Detection of picogram quantities of gelatinases
Kleiner, Anal. Biochem. 1(), 1994
MDC9, a widely expressed cellular disintegrin containing SH3 ligand domains
Weskamp, J. Cell Biology 132(), 1996
Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 11162388
PubMed | Europe PMC

Suchen in

Google Scholar